Dr. Andrew Jacob Brenner - NPI #1700909744

Medical Oncologist located in San Antonio, TX

Texas San Antonio Medical Oncology Dr. Andrew Jacob Brenner Information


Dr. Andrew Jacob Brenner is a male Medical Oncologist (taxonomy code 207RX0202X) located in San Antonio, Texas. Dr. Andrew Jacob Brenner primarily specializes in Medical Oncology but also specializes in and Internal Medicine. Dr. Andrew Jacob Brenner's NPI Number is #1700909744 and has been listed in the NPI registry for 11 years. Dr. Andrew Jacob Brenner's practice location is listed as: 7979 Wurzbach Rd San Antonio, TX 78229-4427 and can be reached via phone at (210) 450-1000.

Medical Oncology Taxonomy

The taxonomy code for Dr. Andrew Jacob Brenner's main specialty, Medical Oncology, is 207RX0202X. An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.



Be the first to rate Dr. Brenner

Thanks for sharing your opinion!

‡ Descriptions, provider messages, and reviews are user submitted. While we make our best effort to verify the accuracy of information submissions, DocBios cannot guarantee that the information is accurate and/or up to date. Please verify any and/or all information with the provider. DocBios is not an advice or referral service and does not guarantee, approve, or endorse any particular healthcare provider.

Health Care Provider Information
 NPI # 1700909744
 Phone (210) 450-1000
 Fax (210) 450-1100
7979 Wurzbach Rd
San Antonio, TX 78229-4427
 Gender M
 Website Not provided
  • Internal Medicine (TX)
  • Medical Oncology (TX)
Business Information
  • Sole Proprietor? No
  • Is Sub-Organization? Not Available
  • Parent Org Name: Not Available
 Updated 8/18/2010
 Added 4/6/2007
 Viewed on 3/24/2018
Health Care Providers Nearby

Thanks! Your edit was sucessfully submitted. Changes will be displayed after DocBios.com editors have reviewed your submission.